Recent advances in nanotechnology have allowed for the effective use of iron oxide nanoparticles (IONPs) for cancer imaging and therapy. When activated by an alternating magnetic field (AMF), intra-tumoral IONPs have been effective at controlling tumor growth in rodent models. To accurately plan and assess IONP-based therapies in clinical patients, noninvasive and quantitative imaging technique for the assessment of IONP uptake and biodistribution will be necessary.
1) INTRODUCTION
The development of iron oxide nanoparticles for hyperthermia applications has great potential for delivering focused and effective cell killing. Pervious hyperthermia methods were hindered by the difficulties of low tumor specificity and the delivery of a quantifiable and repeatable thermal dose to the targeted tissue while avoiding normal tissue toxicity. Because of the localized nature of delivery mechanism (the heat sources are within the cells) and the promise of future specificity via protein / antibody targeting, the technology has great potential. The IONP used by our group, for IONP hyperthermia (IONPHT), are Fe 3 O 4 cores with a biocompatible hydroxyethyl starch coating (Micromod Partikeltechnologie GmbH (18119 Rostock-Warnemuende, GERMANY)). When an alternating magnetic field is applied (170 kHz and 400-600 Oe) the particles heat via hysteresis, with significant tumor regrowth delay demonstrated in vitro, in murine breast cancer models and spontaneous oral canine tumors, both alone and with adjuvant radiation and chemotherapy The ability to accurately measure the in vivo distribution of IONP is essential to develop IONPHT into a clinical cancer treatment. Through our own efforts (Dartmouth and University of Minnesota), we have determined that standard MR imaging techniques are unable to visualize concentrations greater than 1mg Fe/g tissue, which studies suggest have the greatest potential to generate significant efficacy. Zhou et al. identified the two primary problems associated with imaging IONP with GRE sequences as: 1) The signal void created by the IONP is larger than the cells containing them, which in bulk tissues is manifested by large "holes" in the image, 2) Signal voids are difficult to distinguish from other sources of T2* shortening, such as the tissue/air boundaries. This results in a negative contrast, with both poor signal-to-noise ratios and specificity. 5 CT imaging is also inadequate as it lacks the sensitivity necessary at the concentrations applied. Although CT is used clinically for measuring IONP, at concentrations at 10 mg Fe/mL tissue and below, the degree of contrast-concentration resolution significantly drops off. 6 Other methods of imaging and quantification such as TEM, histology techniques, and ICP-MS lack the ability to measure IONP levels in living tissue. Furthermore, although they have many applications in experimental settings, florescence methods are impractical in the clinic. The presented data and images demonstrate the aforementioned shortcomings of the standard techniques as well as propose a promising solution in the form of the Sweep Imaging With Fourier Transformation (SWIFT) MR method.
2) METHODOLOGY
2.1 Iron Oxide Nanoparticles: BNF-IONPs consist of a magnetite core, coated with biocompatible hydroxyethyl starch (110-120 nm hydrodynamic diameter). acquired from Micromod Partikeltechnologie GmbH (18119 RostockWarnemuende, GERMANY). The mouse was anesthetized and scanned in the manner described previously. The animal was removed from the MR and injected in the prescribed manner, and then scanned again immediately following injection using the same imaging parameters (Figure 2 ). Mouse 2: The mouse was anesthetized and injected in the manner described previously. The mouse was sacrificed 15 minutes following the injection and imaged with the two acquisition parameters described. CT images were also acquired at this time. Following the CT imaging procedures the tumor was excised, photographed, fixed in formaldehyde, processed for histologic iron staining /Prussian Blue (Figure 3,4,5) . Dog: A 10 years old female Schnauzer presented with a oral tumor (Acanthomatous Ameloblastoma) associated with the upper left canine tooth. Upon exam, the dog was anesthetized and the tumor and surrounding area were imaged with conventional T1 and T2 MRI pulse sequences (Figure 6 ).
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3) RESULTS
Mouse 1 Results:
The spin echo images of Mouse 1 show the appearance of tumor tissue with and without IONP. The darkening within the tumor tissue demonstrates the significant voids that result from the presence of the IONP. 
Mouse 2 Results:
Regions of high IONP contrast can be seen in the images from both the T1 and T2 scans, although differentiation at the highest concentration is impaired due both the resulting negative contrast with which signal decreases with increasing concentration, and to signal voids which are significantly greater than the IONP volume. Micro-CT images acquired over the same time period were also unable to distinguish different regions of IONP concentration. However, variations in IONP concentration can be seen within the excised tumor tissue (bulk IONP appear black). Histology confirms significant variation of Fe content as well as movement and aggregation. 
Dog Results:
As illustrated in the MRI image below, the imaging artifact created by the low number of IONP was significant and made visualization of the tumor impossible with the applied imaging sequences. Without a suitable imaging method not only will the ability to effectively predict thermal dose be compromised, but the ability to gauge treatment efficacy will be hindered as well. 
Phantom Results:
The Sweep Imaging With Fourier Transformation MR method (SWIFT) is suited for the imaging of IONP as the time between excitation and signal acquisition is very short. 7 Unlike with traditional MRI methods, such as gradient-echo or spin-echo, with which IONP appear as negative contrast, IONP are presented as positive contrast which is easier to accurately distinguish from other tissues or the air-tissue boundary, and therefore, accurately quantify. 5 Figure 7: Positive contrast for super-paramagnetic iron-oxide nanoparticles using SWIFT. Shown are images of 5 tubes containing different concentrations of MNPs (Ferrotec (Santa Clara, CA 95054 USA) EMG-308; diameter ~10 nm) in 1% agarose gel, placed in a beaker of pure saline. Images were acquired with (A) GRE, (B) SE, and (C) SWIFT. With GRE and SE, there is a decrease in tube signal (the water signal in the tubes is normalized to the saline water signal in the beaker) with nanoparticle concentration, whereas with SWIFT the signal increases with concentration (D).
4) DISCUSSION
In this paper we demonstrate the importance and difficulty of observing and quantifying iron concentrations in the clinically relevant range for cancer therapy. We have shown that conventional CT and MRI techniques are not capable of adequately imaging or quantifying IONPs in tissues and are thus not useful for IONP hyperthermia treatment planning. We believe a new ultra-short T2 MRI technique (SWIFT) has excellent potential in this regard. Our feasibility studies suggest the SWIFT technique can be accurate over the range of iron concentrations utilized in both intra-tumoral and systemic IONP cancer therapy.
A very important IONP associated imaging issue, that is only briefly addressed here, pertains to the IONP cellular uptake mechanism and kinetic variability present in different tumors and normal tissues. These differences have extremely important ramifications with respect IONP magnetic behavior (T1 and SAR values) and therapeutic potential (heating capability). Ongoing studies at Dartmouth have shown that SAR drastically increases when IONPs are aggregated together in a conformation of 200 nm or greater. 8 This finding is important especially if the MRI signal changes due to aggregation, which will lead to a more quantifiable assessment of nanoparticle behavior and prediction of thermal dose in the clinical settings. ). This study showed that all IONPs are either aggregated inside cells or had been eliminated from the tumor extracellular space after 24 hrs. The average size of the aggregates found is significantly larger than 200nm, the size at which SAR values dramatically increase. 8 Such aggregation may also be detectable with SWIFT MRI.
In summary, the establishment of an imaging method capable of accurately observing and quantify the concentration and distribution of both directly and systemically injected IONP is critical for the future clinical application of IONP hyperthermia cancer treatment. Although CT and other MRI methods are able to image IONP at higher or lower concentrations, the SWIFT MRI method is uniquely suited to image concentrations which are relevant for clinical IONPHT applications.
